On the importance and challenges of global access to proven life-saving treatments for Ebolavirus - Authors' reply
| Errataetall: |
CommentOn: Lancet Infect Dis. 2023 Jan 19;:null. - PMID 36682365 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
The Lancet. Infectious diseases - 23(2023), 4 vom: 03. Apr., Seite 407-408 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Torreele, Els [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 28.03.2023 Date Revised 30.06.2023 published: Print CommentOn: Lancet Infect Dis. 2023 Jan 19;:null. - PMID 36682365 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1473-3099(23)00127-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354690477 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354690477 | ||
| 003 | DE-627 | ||
| 005 | 20231226062747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(23)00127-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1182.xml |
| 035 | |a (DE-627)NLM354690477 | ||
| 035 | |a (NLM)36963917 | ||
| 035 | |a (PII)S1473-3099(23)00127-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Torreele, Els |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a On the importance and challenges of global access to proven life-saving treatments for Ebolavirus - Authors' reply |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.03.2023 | ||
| 500 | |a Date Revised 30.06.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Lancet Infect Dis. 2023 Jan 19;:null. - PMID 36682365 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 700 | 1 | |a Boum, Yap |c 2nd |e verfasserin |4 aut | |
| 700 | 1 | |a Adjaho, Ismael |e verfasserin |4 aut | |
| 700 | 1 | |a Alé, Franck Guy Biaou |e verfasserin |4 aut | |
| 700 | 1 | |a Issoufou, Sal Ha |e verfasserin |4 aut | |
| 700 | 1 | |a Harczi, Geza |e verfasserin |4 aut | |
| 700 | 1 | |a Okonta, Chibuzo |e verfasserin |4 aut | |
| 700 | 1 | |a Olliaro, Piero |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Infectious diseases |d 2001 |g 23(2023), 4 vom: 03. Apr., Seite 407-408 |w (DE-627)NLM117564362 |x 1474-4457 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:4 |g day:03 |g month:04 |g pages:407-408 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1473-3099(23)00127-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 4 |b 03 |c 04 |h 407-408 | ||